BMJ, doi: 10.1136/bmj.39063.689375.55, (Published 19 January 2007)

RESEARCH

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

Clare L Gillies ^1*, Keith R Abrams ¹, Paul C Lambert ¹, Nicola J Cooper ¹, Alex J Sutton ¹, Ron T Hsu ¹, Kamlesh Khunti ²

¹ Centre for Biostatistics and Genetic Epidemiology, Department of Health Sciences, University of Leicester, Leicester LE1 7RH
² Clinical Division of General Practice and Primary Health Care, Department of Health Sciences, University of Leicester

^* Correspondence to: clg13{at}le.ac.uk.

Objective To quantify the effectiveness of pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance.

Data sources Medline, Embase, and the Cochrane library searched up to July 2006. Expert opinions sought and reference lists of identified studies and any relevant published reviews checked.

Study selection Randomised controlled trials that evaluated interventions to delay or prevent type 2 diabetes in individuals with impaired glucose tolerance.

Results 21 trials met the inclusion criteria, of which 17, with 8084 participants with impaired glucose tolerance, reported results in enough detail for inclusion in the meta-analyses. From the meta-analyses the pooled hazard ratios were 0.51 (95% confidence interval 0.44 to 0.60) for lifestyle interventions v standard advice, 0.70 (0.62 to 0.79) for oral diabetes drugs v control, 0.44 (0.28 to 0.69) for orlistat v control, and 0.32 (0.03 to 3.07) for the herbal remedy jiangtang bushen recipe v standard diabetes advice. These correspond to numbers needed to treat for benefit (NNTB) and harm (NNTH) of 6.4 for lifestyle (95% credible interval, NNTB 5.0 to NNTB 8.4), 10.8 for oral diabetes drugs (NNTB 8.1 to NNTB 15.0), 5.4 for orlistat (NNTB 4.1 to NNTB 7.6), and 4.0 for jiangtang bushen (NNTH 16.9 to NNTB 24.8).

Conclusions Lifestyle and pharmacological interventions reduce the rate of progression to type 2 diabetes in people with impaired glucose tolerance. Lifestyle interventions seem to be at least as effective as drug treatment.

---

(Accepted 28 November 2006)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Find additional patient-related information at:

Vildagliptin Effective in Previously Untreated People with Diabetes

Lifestyle Changes as Effective as Drugs in Treating Pre-Diabetes

This article has been cited by other articles:

• Bloomgarden, Z. T. (2008). Approaches to Treatment of Pre-Diabetes and Obesity and Promising New Approaches to Type 2 Diabetes. Diabetes Care 31: 1461-1466 [Full text]  
• Bassuk, S. S., Manson, J. E. (2008). Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2: 191-213 [Abstract]  
• Gillies, C. L, Lambert, P. C, Abrams, K. R, Sutton, A. J, Cooper, N. J, Hsu, R. T, Davies, M. J, Khunti, K. (2008). Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336: 1180-1185 [Abstract] [Full text]  
• Goyder, E. C (2008). Screening for and prevention of type 2 diabetes. BMJ 336: 1140-1141 [Full text]  
• Lindstrom, J., Peltonen, M., Eriksson, J. G., Aunola, S., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Uusitupa, M., Tuomilehto, J., for the Finnish Diabetes Prevention Study (DPS) Gr, (2008). Determinants for the Effectiveness of Lifestyle Intervention in the Finnish Diabetes Prevention Study. Diabetes Care 31: 857-862 [Abstract] [Full text]  
• Rucker, D., Padwal, R., Li, S. K, Curioni, C., Lau, D. C W (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 335: 1194-1199 [Abstract] [Full text]  
• Preiss, D., Sattar, N. (2007). Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart 93: 1493-1496 [Abstract] [Full text]  
• Villar, E., Chang, S. H., McDonald, S. P. (2007). Incidences, Treatments, Outcomes, and Sex Effect on Survival in Patients With End-Stage Renal Disease by Diabetes Status in Australia and New Zealand (1991 2005). Diabetes Care 30: 3070-3076 [Abstract] [Full text]  
• Terre, L. (2007). Behavioral Medicine Review: Strategic Management of Diabetes Risk. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 1: 351-355 [Abstract]  
• Marrero, D. G., Ackermann, R. T. (2007). Providing Long-Term Support for Lifestyle Changes: A Key to Success in Diabetes Prevention. Diabetes Spectr. 20: 205-209 [Abstract] [Full text]  
• Bhagra, S., Smith, S. A (2007). Review: lifestyle or pharmacological interventions prevent or delay type 2 diabetes in impaired glucose tolerance. Evid. Based Med. 12: 108-108 [Full text]  
• Upchurch, S. L (2007). Review: lifestyle or pharmacological interventions prevent or delay type 2 diabetes in people with impaired glucose tolerance. Evid. Based Nurs. 10: 78-78 [Full text]  
• (2007). Using Lifestyle or Drug Interventions to Prevent or Delay Progression to Type 2 Diabetes. JWatch General 2007: 1-1 [Full text]  

Rapid Responses:

Read all Rapid Responses

Glucose values should be reported

Ingrid Mühlhauser
bmj.com, 14 Feb 2007 [Full text]

Lifestyle Changes and/or Drugs for overweight patients without obesity ?

PATRICE COUZIGOU, et al.
bmj.com, 15 Feb 2007 [Full text]

Re: Glucose values should be reported

Clare L Gillies, et al.
bmj.com, 23 Feb 2007 [Full text]

Re: Lifestyle Changes and/or Drugs for overweight patients without obesity ?

Clare L Gillies, et al.
bmj.com, 23 Feb 2007 [Full text]

Re: Re: Glucose values should be reported

Ingrid Mühlhauser
bmj.com, 28 Feb 2007 [Full text]